Distribution of Bexsero® antigen sequence types (BASTs) in invasive meningococcal disease isolates: implications for immunisation

Distribution of Bexsero® antigen sequence types (BASTs) in invasive meningococcal disease isolates: implications for immunisation

Serogroup B is the only major disease-associated capsular group of Neisseria meningitidis for which no protein-polysaccharide conjugate vaccine is available. This has led to the development of multi-component protein-based vaccines that target serogroup B invasive meningococcal disease (IMD), inclu...

Detaylı Bibliyografya
Asıl Yazarlar:	Brehony, C, Rodrigues, C, Borrow, R, Smith, A, Cunney, R, Moxon, E, Martin C.J., M
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	Elsevier 2016

Benzer Materyaller

Genomic surveillance and meningococcal group B vaccine coverage estimates after introduction of the vaccine into the national immunisation programme in the UK
Yazar:: Rodrigues, C, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme.
Yazar:: Marcello Tirani, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Meningococcal meningitis presenting postinfant group B meningococcal immunisation
Yazar:: So, N, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Progressive decrease in the potential usefulness of meningococcal serogroup B vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain.
Yazar:: Emilio Pérez-Trallero, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands
Yazar:: Josefien Cornelie Minthe Bousema, ve diğerleri
Baskı/Yayın Bilgisi: (2015-11-01)

Resolution of a protracted serogroup B meningococcal outbreak with whole genome sequencing shows inter species genetic transfer.
Yazar:: Mulhall, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Product review on the IMD serogroup B vaccine Bexsero®
Yazar:: Ala-Eddine Deghmane, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.
Yazar:: Shakeel Mowlaboccus, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
Yazar:: Eva Hong, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
Yazar:: George Kassianos, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Correction to: Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
Yazar:: George Kassianos, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines
Yazar:: Chen Stein-Zamir, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

The Prevalence of Invasive Bacterial Infection in Febrile Infants Presenting to Hospital Following Meningococcal B Immunisation: A Case Series
Yazar:: Holly Drummond, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Identification of novel antigens that protect against systemic meningococcal infection.
Yazar:: Sun, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

UKMenCar4: a cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence
Yazar:: Bratcher, H, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

The price of prevention: what now for immunisation against meningococcus B?
Yazar:: Moxon, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
Yazar:: Alessia Biolchi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Meningococcal antigen in diagnosis and treatment of group A meningococcal infections.
Yazar:: Whittle, H, ve diğerleri
Baskı/Yayın Bilgisi: (1975)

Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.
Yazar:: Désirée E Bennett, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

MEMORY B CELL RESPONSES FOLLOWING IMMUNISATION WITH POLYSACCHARIDE AND CONJUGATE QUADRIVALENT MENINGOCOCCAL ACYW135 VACCINES IN HEALTHY ADULT VOLUNTEERS
Yazar:: Maheshi, R, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Bast and other plant fibres /
Yazar:: Franck, Robert R.
Baskı/Yayın Bilgisi: (2005)

Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study
Yazar:: Hill, DMC, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Invasive meningococcal disease
Yazar:: Vanessa L. Strelow, ve diğerleri
Baskı/Yayın Bilgisi: (2013-09-01)

Cardiac transplantation and immunisation against Haemophilus influenzae.
Yazar:: Barbour, M, ve diğerleri
Baskı/Yayın Bilgisi: (1993)

Hemma är bäst
Yazar:: Mikael Andersson
Baskı/Yayın Bilgisi: (2016-08-01)

Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol
Yazar:: Eric P F Chow, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

T-cell responses against meningococcal antigens.
Yazar:: Næss, L, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Genomic Analysis of the Evolution and Global Spread of Hyper-invasive Meningococcal Lineage 5
Yazar:: Odile B. Harrison, ve diğerleri
Baskı/Yayın Bilgisi: (2015-03-01)

Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.
Yazar:: Collins, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results
Yazar:: Maclennan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results
Yazar:: MacLennan, JM, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

The important lessons lurking in the history of meningococcal epidemiology
Yazar:: Ray Borrow, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.
Yazar:: Snape, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
Yazar:: Sathyavani Subbarao, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España
Yazar:: Rafael Ruiz-Montero, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Invasive meningococcal disease in Shanghai, China from 1950 to 2016: implications for serogroup B vaccine implementation
Yazar:: Chen, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Metonymy Basted on the Prespective of Rhetoric
Yazar:: محمد غلامرضایی
Baskı/Yayın Bilgisi: (2013-12-01)

Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.
Yazar:: Nagaputra, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Determination of antibody responses to meningococcal antigens by ELISA.
Yazar:: Rosenqvist, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Presentations at the UK National Immunisation Conference
Yazar:: Pollard, AJ, ve diğerleri
Baskı/Yayın Bilgisi: (2022)